JAZZ vs SPIR · P/E 1988, rev $4.07B vs rev $110.5M
Jazz Pharmaceuticals PLC (JAZZ) versus Spire Global Inc (SPIR) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Spire Global Inc (SPIR) is a specialty business services company listed on US.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported SPIR revenue for 2024-12-31 was $110.5M. Net income was -$102.8M. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. SPIR currently screens at market cap $351.2M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. SPIR currently screens at market cap $351.2M.
Not investment advice. Open the JAZZ and SPIR stock pages for the full models.
Not investment advice.